Aardvark Therapeutics AARD
NASDAQ AARD
$6.82 +0.93 (+15.79%)
At close: Aug 21, 2026 · 4:00 PM EDT

Aardvark Therapeutics (AARD) Amortizatization of Intangibles (2024 - 2026)

Aardvark Therapeutics (AARD) posted Amortizatization of Intangibles of $118000.0 for Q1 2026, down 49.36% sequentially from $233000.0 in Q4 2025, and up 45.68% YoY from $81000.0 in Q1 2025.

Aardvark Therapeutics (AARD) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends

Aardvark Therapeutics has reported Amortizatization of Intangibles for 3 years, with the latest figure at $118000.0 in Q1 2026.

  • Quarterly Amortizatization of Intangibles rose 45.68% year-over-year to $118000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (up 658.76% YoY) and the FY2025 annual result came in at $1.3 million, up 1260.42% from the prior year.
  • Amortizatization of Intangibles eased to $118000.0 in Q1 2026 per AARD's latest filing, from $233000.0 in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $620000.0 in Q2 2025 and troughed at $81000.0 in Q1 2025.
  • A 3-year average of $253333.3 and a median of $175500.0 in 2025 frame the typical range for Amortizatization of Intangibles.
  • The sharpest annual moves came in 2025 and 2026: Amortizatization of Intangibles jumped 142.71% in 2025, then jumped 45.68% in 2026.
  • Over 3 years, Amortizatization of Intangibles stood at $96000.0 in 2024, then surged by 142.71% to $233000.0 in 2025, then sank by 49.36% to $118000.0 in 2026.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $118000.0, $233000.0, and $372000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 678,000.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Aardvark Therapeutics 147.46 Mn 73.54 Mn - 19,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 19,000.00
Jun 30, 2026 19,000.00
Mar 31, 2026 118,000.00
Mar 31, 2026 118,000.00
Dec 31, 2025 233,000.00
Dec 31, 2025 233,000.00
Sep 30, 2025 372,000.00
Sep 30, 2025 372,000.00
Jun 30, 2025 620,000.00
Jun 30, 2025 620,000.00
Mar 31, 2025 81,000.00
Mar 31, 2025 81,000.00
Dec 31, 2024 96,000.00
Dec 31, 2024 96,000.00